Omeros Q4 Earnings Call Highlights [Yahoo! Finance]
Omeros Corporation (OMER)
Last omeros corporation earnings: 3/2 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.omeros.com
Company Research
Source: Yahoo! Finance
including milestones, plus tiered royalties, while retaining rights to its MASP-3 small-molecule program and certain antibody rights under a transition services agreement. The FDA approved Omeros' MASP-2 inhibitor YARTEMLEA for TA-TMA, with early U.S. launch activity underway: distributors supplied in January, third-party reimbursement obtained, a per-vial price of about , median use of 8–10 vials per course, and initial formulary placements at top transplant centers. Q4 results showed $86.5 million net income driven by a $237.6 million gain on the zaltenibart sale, ending 2025 with $171.8 million in cash and investments and significant debt reduction (remaining $70.8 million 2029 convertibles), with management targeting a self-sustaining YARTEMLEA program in 2026 and positive cash flow by 2027. Interested in Omeros Corporation? Here are five stocks we like better. Breakout Momentum Plays You Need to Know About Omeros (NASDAQ:OMER) executives highlighted two “major successes
Show less
Read more
Impact Snapshot
Event Time:
OMER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OMER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OMER alerts
High impacting Omeros Corporation news events
Weekly update
A roundup of the hottest topics
OMER
News
- Omeros: Making The Bull Case On Q4 Earnings, Ahead Of Key Q1 Commercial Updates [Seeking Alpha]Seeking Alpha
- Omeros Corporation (OMER) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial ResultsBusiness Wire
- Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026 [Yahoo! Finance]Yahoo! Finance
- Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026Business Wire
OMER
Earnings
- 3/31/26 - Beat
OMER
Sec Filings
- 3/31/26 - Form 10-K
- 3/31/26 - Form 8-K
- 3/27/26 - Form SCHEDULE
- OMER's page on the SEC website